Cargando…

Obesity increases cardiovascular mortality in patients with HFmrEF

BACKGROUND: High body mass index increases the risk of heart failure morbidity and mortality. It is unclear whether a high body mass index is associated with prognosis in patients with heart failure with mildly reduced left ventricular ejection fraction (HFmrEF). We retrospectively analyzed the effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhican, Peng, Yiqun, Zhao, Wenjiao, Zhu, Yunlong, Wu, Mingxin, Huang, Haobo, Peng, Ke, Zhang, Lingling, Chen, Sihao, Peng, Xin, Li, Na, Zhang, Hui, Zhou, Yuying, Chen, Yongliang, Xiao, Sha, Fan, Jie, Zeng, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497875/ https://www.ncbi.nlm.nih.gov/pubmed/36158802 http://dx.doi.org/10.3389/fcvm.2022.967780

Ejemplares similares

Impact of signs and symptoms on the prognosis of patients with HFmrEF
por: Liu, Zhican, et al.
Publicado: (2023)

Risk factors of short‐term, intermediate‐term, and long‐term cardiac events in patients hospitalized for HFmrEF
por: Zhu, Yunlong, et al.
Publicado: (2022)

Similarities and Differences Between HFmrEF and HFpEF
por: Li, Peixin, et al.
Publicado: (2021)

Editorial: HFpEF and HFmrEF: Different Sides of the Same Coin?
por: Martínez-Sellés, Manuel, et al.
Publicado: (2022)

Are HFpEF and HFmrEF So Different? The Need to Understand Distinct Phenotypes
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

CMR Tissue Characterization in Patients with HFmrEF
por: Doeblin, Patrick, et al.
Publicado: (2019)

Mortality and Morbidity in HFrEF, HFmrEF, and HFpEF Patients with Diabetes in the Middle East
por: Al-Jarallah, Mohammed, et al.
Publicado: (2020)

Racial differences of heart failure with midrange ejection fraction (HFmrEF): a large urban centre-based retrospective cohort study in the USA
por: Li, Dan Leslie, et al.
Publicado: (2019)

Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?()
por: Webb, Jessica, et al.
Publicado: (2018)

Aging-Related Endothelial Progenitor Cell Dysfunction and Its Association with IL-17 and IL-23 in HFmrEF Patients
por: Zeng, Lijin, et al.
Publicado: (2022)

Sex differences in patients with heart failure and mildly reduced left ventricular ejection fraction
por: Liu, Zhican, et al.
Publicado: (2023)

Red blood cell count and risk of adverse outcomes in patients with mildly reduced left ventricular ejection fraction
por: Liu, Zhican, et al.
Publicado: (2023)

Impact of atrial fibrillation on cerebro‐cardiovascular outcome of heart failure with mildly‐reduced ejection fraction
por: Li, Na, et al.
Publicado: (2023)

Ejection fraction at hospital admission stratifies mortality risk in HFmrEF patients aged ≥ 70 years: a retrospective analysis from a tertiary university institution
por: Sonaglioni, Andrea, et al.
Publicado: (2023)

Impact of B‐lines‐guided intensive heart failure management on outcome of discharged heart failure patients with residual B‐lines
por: Zhu, Yunlong, et al.
Publicado: (2022)

The “Obesity Paradox” in Patients With HFpEF With or Without Comorbid Atrial Fibrillation
por: Guo, Linjuan, et al.
Publicado: (2022)

Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF
por: Mangner, Norman, et al.
Publicado: (2023)

Characteristics, prognosis, and treatment response in HFpEF patients with high vs. normal ejection fraction
por: Gu, Jun, et al.
Publicado: (2022)

Predictors and Mortality for Worsening Left Ventricular Ejection Fraction in Patients With HFpEF
por: Chen, Liling, et al.
Publicado: (2022)

The Diagnostic and Prognostic Value of Plasma Galectin 3 in HFrEF Related to the Etiology of Heart Failure
por: Lu, Qun, et al.
Publicado: (2021)

Becker muscular dystrophy with dilated cardiomyopathy: A case report
por: Chen, Yongliang, et al.
Publicado: (2021)

RBM20, a Therapeutic Target to Alleviate Myocardial Stiffness via Titin Isoforms Switching in HFpEF
por: Li, Na, et al.
Publicado: (2022)

Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF
por: Guo, Yanhong, et al.
Publicado: (2022)

Chronic Kidney Disease Increases Risk of Incident HFrEF Following Percutaneous Coronary Intervention
por: Lai, Wenguang, et al.
Publicado: (2022)

Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis
por: He, Yibo, et al.
Publicado: (2021)

Large Animal Models of Heart Failure With Reduced Ejection Fraction (HFrEF)
por: Spannbauer, Andreas, et al.
Publicado: (2019)

Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)
por: Valero-Muñoz, María, et al.
Publicado: (2022)

Vascular dysfunction in HFpEF: Potential role in the development, maintenance, and progression of the disease
por: Saavedra-Alvarez, Andrea, et al.
Publicado: (2022)

Prognostic Value of Right Ventricular 3D Speckle-Tracking Strain and Ejection Fraction in Patients With HFpEF
por: Meng, Yuanli, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design
por: Ali, Danish, et al.
Publicado: (2019)

Validation and Utilization of a Clinical Next-Generation Sequencing Panel for Selected Cardiovascular Disorders
por: Celestino-Soper, Patrícia B. S., et al.
Publicado: (2017)

Causal effect of central obesity on left ventricular structure and function in preserved EF population: A Mendelian randomization study
por: Gao, Yue, et al.
Publicado: (2023)

Association Between Metabolic Syndrome and an Increased Risk of Hospitalization for Heart Failure in Population of HFpEF
por: Zhou, Ying, et al.
Publicado: (2021)

The loss of left atrial contractile function predicts a worse outcome in HFrEF patients
por: Mandoli, Giulia Elena, et al.
Publicado: (2023)

Role and Mechanism of PKC-δ for Cardiovascular Disease: Current Status and Perspective
por: Miao, Li-na, et al.
Publicado: (2022)

Is there any difference in the therapeutic effects of Levosimendan on advanced HFrEF patients with sinus rhythm or atrial fibrillation?
por: Wang, Wenyan, et al.
Publicado: (2023)

A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al(18)F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease
por: Lyu, Zhehao, et al.
Publicado: (2022)

Diabetes Is the Strongest Predictor of Limited Exercise Capacity in Chronic Heart Failure and Preserved Ejection Fraction (HFpEF)
por: Berisha-Muharremi, Venera, et al.
Publicado: (2022)

The association between iliac vein compression degree and characteristics of first diagnosed left lower extremity deep vein thrombosis
por: Shi, Yadong, et al.
Publicado: (2022)

EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells
por: Zou, Peng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cptt0jff4gt88ufllm2gvhqil3